MaineHealth Innovation Impact
Since MaineHealth Innovation’s launch in 2020, innovators from all three regions continue to contribute to the dynamic landscape. The breadth of novel solutions encompass; a screening tool crafted by an Emergency Department psychiatrist to safeguard care team members against workplace violence; a behavioral health treatment strategy for opioid addition from an obstetrics nurse manager; and a novel cancer therapeutic from a scientist at MHIR. These highlights exemplify the diversity of the novel solutions coming from our 23,000 care team member who are experts in care to potentially solve the unmet clinical care needs.
We are proud of what we’ve accomplished thus far and excited about continuing to extend our impact across the MaineHealth system.
MaineHealth Academic Affairs Annual Report
MaineHealth Innovation builds connections to drive diversity of thought, educates to produce creative problem-solvers, and funds to accelerate ideas. By leveraging the ideas, insights and expertise of all care team members to develop novel solutions to our unmet care needs, we are working together so our communities are the healthiest in America.
CAPE, LLC. (Collapsible Aerosolized Particle Enclosure), Protects patients and providers exposed to infectious airborne particles
Team: Samir Haydar, MD, Emergency Physician, MMC; Kaitlyn Main, MD, Emergency Resident, MMC; Liz Hamilton, MD, Emergency Resident, MMC; Paul Fitzpatrick, Medical Device Entrepreneur; Paul Tyson, Thermoformed Plastics; David Eagleson, Baker, Co
Teach Me Rx, Creator of Pocket Nodules, a visually engaging learning experience for improved understanding of lung nodules. It may also reduce anxiety and encourage lung health stewardship for patients.
Current Status: The patient education tool is being used in select clinics in the US, Europe, Asia, Africa, Canada and South America as well as at MaineHealth Pen Bay Medical Center ED for explaining incidental pulmonary modules.
Team: Theresa Roelke, Adult Nurse Practitioner, Maine Health Institute of Research Maine Medical Partners
Acuity, LLC. Acuity Behavioral Health was founded by a consortium of the nation’s leading behavioral health organizations, and the company’s product, the BHAI, is a predictive decision-support solution created as a clinical response to the increasingly acute status of mental health patients in inpatient settings. The BHAI provides an accurate and consistent measurement of patient acuity in behavioral healthcare settings to assist nursing staff administrators in planning for next-day staffing and patient needs.
Current Status: Acuity has received approval for implementing at MaineHealth and will begin with training staff at Spring Harbor Hospital to begin utilizing the tool with eventual expansion to all inpatient behavioral health locations across MaineHealth (Southern Maine Health Care, PenBay, MidCoast and MMC). The tool is currently being utilized at PineRest in Michigan and Cone Health in North Carolina.
Team: Kelly Barton, President, Maine Behavioral Healthcare, Jason Rosenberg, CNO for Maine Behavioral Healthcare
MaineHealth is excited to be a partner and investor in the Roux Institute’s Future of Healthcare Founder Residency, the first of its kind in northern New England.
“Programs like the Future of Healthcare Founders Residency have the real potential to improve patient care, reduce healthcare costs and allow our care team to collaborate with community members on the evidence-based treatments of tomorrow right here in Maine,” said MaineHealth CEO Andy Mueller, MD. “MaineHealth is proud to partner with the Roux on this project as part of our vision of working together so our communities are the healthies in America.”
The year-long program was developed in partnership with MaineHealth and Northern Light Health, two of Maine’s leading healthcare providers, as well as the Maine Venture Fund. The future of Healthcare Founder Residency is an exciting community collaboration aimed at identifying promising new healthtech start-ups to address unmet care needs while simultaneously cultivating a dynamic workforce and economy here in Maine. The program is a novel example of our vision and working together so our communities are the healthiest in America.
MaineHealth care team members have already engaged with companies as experts, collaborators and educators. 2023 Future of Health Founder Residency Portfolio companies are listed below and care team members who are interested in getting involved or connecting with any of these companies are encouraged reach out to innovation_center@mainehealth.org
- 119 – A patent-pending medical alert system that enables bystanders and emergency responders to act according to the wishes of the individual
- Althea – A virtual AI workforce for healthcare that supports the human workforce to greatly enhance patient experience and access, increase revenue and utilization, and drive operational efficiency
- Apricot – A demographic and geographic platform upon which local data can be grafted, community-level analysis can be performed, and future-looking models can be constructed
- Empallo – An AI platform for saving hearts. Empallo’s mission is to advance cardiovascular care by discovering new insights from data and translating insights into beneficial action
- EmTech Care Labs – An early stage digital health company developing Care-Wallet, a personalized care management platform that simplifies family caregiving for older adults with neurodegenerative disorders like Alzheimer’s and related dementias
- Mother of Fact – For women’s health clinics, a digital health platform that connects patients with critical access to registered dietitians
- PragmaClin – A combined hardware-software solution for capturing neurological disease motor and non-motor data without the use of wearable sensors. Uses machine learning to objectively score disease progression and have clinician and patient dashboards for trend-tracking and disease management
- Radiolife – Developed a proprietary technology that combines radio frequency signatures with AI modeling to enable the rapid and cost-effective detection of viruses, bacteria, and cancer cells
- Stratos Medical – Solving challenges inherent in long-term or repetitive vascular access, such as poor patient experience, needlestick injuries and damage to blood vessels